Pain Perception: on Relationships Between Dental Anxiety and Olfaction
Study Details
Study Description
Brief Summary
the objective of this study is to evaluate the ability of olfaction in obtaining positive emotional and behavioral responses toward dental anxiety and pain in patients undergoing different dental procedures.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
All patients who meet inclusion criteria of the study will be given a written consent and enrolled into a randomized double-blinded controlled study (investigator and patients are blinded about the study). Patients will be divided into lavender and control groups. Patients in lavender group will subjected 2 % lavender vapors. In control group, patients will inhale distal water vapors
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Lavender group On the day of the lavender group, after filling the first phase questionnaire, 20 drops of the lavender oil will be added to the electrical aromatherapy vaporizer near the patient's chair at a distance of 20 cm in the waiting room. After 20 minutes, the second phase questionnaire will be given to the patient, and then the patient will be transformed to dental clinics in which the lavender vaporizer will be placed near the dental unit at a distance of 20 cm. The vaporizer will be also prepared by adding 20 drops of the lavender which will be added added every 20 minutes until the dental sitting will be finalized, and the third questionnaire will be answered. At home, the patients will be asked to pour 3 drops of the lavender on a pad and inhale it for 5 minutes from 10 cm distance every one hour until they attend on the next day to answer the fourth questionnaire. |
Other: Aromatherapy
Lavender will be inhaled through three phases
Other Names:
|
| Placebo Comparator: Placebo group The plain distal water vapors will be used as placebo, the good ventilation of the waiting room and clinics will be performed to ensure that the lavender scent is completely removed from the environment. The patients will inhale the vapors of the plain distal water |
Other: Placebo
Vapors of the distal water will be inhaled through three phases
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Anxiety score [20 minutes before exposure to vapors]
This is calculated by assigning scores of 0, 1, 2, and 3 to the response categories, respectively, of "not at all," "several days," "more than half the days," and "nearly every day." GAD-7 total score for the seven items ranges from 0 to 21. 0-4: minimal anxiety 5-9: mild anxiety 10-14: moderate anxiety 15-21: severe anxiety
- Anxiety score [20 minutes After exposure to vapors]
This is calculated by assigning scores of 0, 1, 2, and 3 to the response categories, respectively, of "not at all," "several days," "more than half the days," and "nearly every day." GAD-7 total score for the seven items ranges from 0 to 21. 0-4: minimal anxiety 5-9: mild anxiety 10-14: moderate anxiety 15-21: severe anxiety
- Anxiety score [24 hours After exposure to vapors]
This is calculated by assigning scores of 0, 1, 2, and 3 to the response categories, respectively, of "not at all," "several days," "more than half the days," and "nearly every day." GAD-7 total score for the seven items ranges from 0 to 21. 0-4: minimal anxiety 5-9: mild anxiety 10-14: moderate anxiety 15-21: severe anxiety
Secondary Outcome Measures
- Pain Score [20 minutes before exposure to vapors]
A person rates their pain on a scale of 0 to 10 Zero means "no pain," 1 to 3 means mild pin 4 to 6 means moderate pain 7 to 10 means severe pain
- Pain Score [20 minutes after exposure to vapors]
A person rates their pain on a scale of 0 to 10 Zero means "no pain," 1 to 3 means mild pin 4 to 6 means moderate pain 7 to 10 means severe pain
- Pain Score [24 hours after exposure to vapors]
A person rates their pain on a scale of 0 to 10 Zero means "no pain," 1 to 3 means mild pin 4 to 6 means moderate pain 7 to 10 means severe pain
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Adult females over 18 years,
-
Attending morning sessions of clinics (9 am)
-
Liable for administration of local anesthesia, tooth preparation either for filling procedures or crown preparations, endodontic treatment, teeth extraction, or subgingival scaling
Exclusion Criteria:
-
Males
-
Females who had allergies, bronchial asthma, common cold, pulmonary diseases, migraine, or taking antidepressants, anxiolytic drugs, opioids, or other medications that affect our results
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Ghada Amin Khalifa | Buraidah | Buraydah | Saudi Arabia | 51452 |
Sponsors and Collaborators
- Qassim University
Investigators
- Principal Investigator: Sarah AM Alkanan, Resident, Qusaiba Hospital, Qassim, Saudi Arabia
- Principal Investigator: Hadeel S Alhaweri, Resident, Aljarirr Alshamali primary health care center, Qassim, Saudi Arabia
- Study Director: Ghada A Khalifa, Professor, College of Dentistry, Qassim University, Saudi Arabia
- Study Chair: Shaimaa MS Ata, Lecturer, College of Dentistry, Qassim University, Saudi Arabia
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- EA/3006/20018